A Due Diligence Process for Highly Leveraged Transactions
نویسندگان
چکیده
منابع مشابه
Due Diligence in Transactions Involving Intellectual Property
The process of gathering information and assessing the merits, issues, and risks associated with a business transaction is called “due diligence,” which is a critical analysis in the acquisition and strategic utilization of intellectual property (IP) assets. Due diligence is a necessary precursor to funding a new venture, and it is critically important in many other business transactions, inclu...
متن کاملHow risky is the debt in highly leveraged transactions?*
This paper estimates the systematic risk of the debt in public leveraged recapitalizations. We calculate this risk as a function of the difference in systematic equity risk before and after the recapitalization. The increase in equity risk is surprisingly small after a recapitalization, ranging from 37% to 57%, depending on the estimation method. If total company risk is unchanged, the implied ...
متن کاملThe Fuzzy MCDM Algorithms for the M&A Due Diligence
An M&A due diligence is the process in which one of the parties to the transaction undertakes to investigate the other in order to judge whether to go forward with the transaction on the terms proposed. It encompasses the missions in three phases: searching and preliminary screening potential candidates, evaluating the candidates and deciding the target, and assisting the after-transaction inte...
متن کاملSix Questions About Translational Due Diligence
C R E D IT : L . C O U RT N E Y /R O C H E ST E R IN ST IT U TE O F TE C H N O LO G Y SECURING SUSTAINABLE RESPECT AND SUPPORT Ensuring that translational research is respected and supported over the long run requires more than the conversion of basic research into technologies that professionals can use to improve medical outcomes and the reverse translation of fi ndings from clinic to bench. ...
متن کاملThe Importance of CRISPR-9 Due Diligence
On February 15, 2017, the United States Patent and Trademark Office’s Patent Trial and Appeal Board announced its long-awaited decision finding no interference-in-fact between patents and patent applications directed to CRISPR-Cas9 owned by Broad Institute, Inc. et al. and patent applications owned by Regents of the University of California et al. The decision found that the CRISPR-Cas9 gene-ed...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Forensic Economics
سال: 1993
ISSN: 0898-5510
DOI: 10.5085/0898-5510-6.3.197